Document Detail

Uric acid and hypertension: cause or effect?
MedLine Citation:
PMID:  20425019     Owner:  NLM     Status:  MEDLINE    
Uric acid was first associated with primary hypertension in 1874, yet its role in this condition remains unclear. Historically, uric acid was thought to be a secondary response to hypertension or its associated conditions. However, more recent experimental and clinical studies suggest that uric acid could have a contributory role in the pathogenesis of elevated blood pressure. More studies are needed to help dissect the potential mechanisms by which uric acid could initiate this response. It remains possible that uric acid is a marker for xanthine oxidase-associated oxidants and that the latter could be driving the hypertensive response. However, the weight of the evidence suggests that uric acid is a true modifying and possibly causal factor for human primary hypertension. Hence, early management of hyperuricemia might delay the development of essential hypertension.
Marilda Mazzali; Mehmet Kanbay; Mark S Segal; Mohamed Shafiu; Diana Jalal; Daniel I Feig; Richard J Johnson
Related Documents :
3486509 - Prevalence of canine uroliths. minnesota urolith center.
359019 - A double-blind comparison of the effects of hydrochlorothiazide and tienylic acid (a di...
8062489 - Effects of probenecid on the pharmacokinetics and pharmacodynamics of adinazolam in hum...
17655019 - Pedot-au nanocomposite films for electrochemical sensing of dopamine and uric acid.
16100229 - Expression of allene oxide cyclase and accumulation of jasmonates during organogenic no...
8321349 - Evidence of defective tubular reabsorption and normal secretion of uric acid in the syn...
22508409 - Amino-acid-based block copolymers by raft polymerization.
6686159 - Purification of three rat atrial natriuretic factors and their amino acid composition.
8191039 - Effects of potassium and lactic acid on ventilation in anaesthetized cats.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current rheumatology reports     Volume:  12     ISSN:  1534-6307     ISO Abbreviation:  Curr Rheumatol Rep     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-04-28     Completed Date:  2010-07-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888970     Medline TA:  Curr Rheumatol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  108-17     Citation Subset:  IM    
Division of Renal Diseases and Hypertension, University of Colorado-Denver, Aurora, CO 80045, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Allopurinol / therapeutic use
Blood Pressure / physiology
Gout Suppressants / therapeutic use
Hypertension / blood,  complications*,  physiopathology
Hyperuricemia / complications*,  drug therapy,  physiopathology
Uric Acid / blood
Reg. No./Substance:
0/Gout Suppressants; 315-30-0/Allopurinol; 69-93-2/Uric Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hyperimmunoglobulin d syndrome in childhood.
Next Document:  Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?